Assignee
ANTABIO SAS
FR·7 granted patents·2 pending applications·4 citations·filing 2014–2023
Top patents by PatentIndex Score
9 records- 0179US11905286B2Diazabicyclooctanones as inhibitors of serine beta-lactamasesANTABIO SAS·Filed 2019·Granted Feb 20, 2024·2 cites·35 claims
- 0276US11000511B2Chemical compounds as antibioticsANTABIO SAS·Filed 2018·Granted May 11, 2021·2 cites·38 claims
- 0367US12378244B2Diazabicyclooctanones as inhibitors of serine β-lactamasesANTABIO SAS·Filed 2023·Granted Aug 5, 2025·0 cites·29 claims
- 0460US2022315546A1Chemical compoundsANTABIO SAS·Filed 2022·Application pending·0 cites
- 0559US12286411B2Indane derivatives for use in the treatment of bacterial infectionANTABIO SAS·Filed 2019·Granted Apr 29, 2025·0 cites·14 claims
- 0659US12247013B2Indane derivatives for use in the treatment of bacterial infectionANTABIO SAS·Filed 2019·Granted Mar 11, 2025·0 cites·40 claims
- 0758US11299467B2Chemical compoundsANTABIO SAS·Filed 2018·Granted Apr 12, 2022·0 cites·28 claims
- 0851US2024016941A1Combination therapyANTABIO SAS·Filed 2021·Application pending·0 cites
- 0950US9914712B2Antibacterial thiazolecarboxylic acidsANTABIO SAS·Filed 2014·Granted Mar 13, 2018·0 cites·36 claims
Join the waitlist — get patent alerts
Get an alert when ANTABIO SAS files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →